Markers of endothelial dysfunction and severity of hypoxaemia in the Eisenmenger syndrome

Cardiology in the Young

Volumn 15, Issue 5, 2005, Pages 504-513

  Soares, Rosangela de P S ^a   Maeda, Nair Y ^a   Bydlowski, Sérgio P ^a   Lopes, Antonio Augusto ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Endothelium; Pulmonary hypertension; Throbomodulin; Tissue type plasminogen activator; Von Willebrand factor

Indexed keywords

DIURETIC AGENT; IRON; THROMBOMODULIN; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR; WARFARIN;

ADOLESCENT; ADULT; ARTICLE; BRAZIL; CHILD; CLINICAL ARTICLE; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; DISEASE SEVERITY; EISENMENGER COMPLEX; ENDOTHELIUM INJURY; ENDOTHELIUM LESION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HOSPITAL CARE; HUMAN; HYPOXEMIA; MALE; OXYGEN SATURATION; PROTEIN BLOOD LEVEL; PULMONARY HYPERTENSION; SYMPTOMATOLOGY; VASCULAR ENDOTHELIUM;

EID: 27744517549     PISSN: 10479511     EISSN: 14671107     Source Type: Journal    
DOI: 10.1017/S1047951105001381     Document Type: Article

References (28)

1. Michiels C, Arnould T, Remacle J. Endothelial cell responses to hypoxia: initiation of a cascade of cellular interactions. Biochim Biophys Acta 2000; 1497: 1-10.
2. Ginis I, Mentzer SJ, Faller DV. Oxygen tension regulates neutrophil adhesion to human endothelial cells via an LFA-1-dependent mechanism. J Cell Physiol 1993; 157: 569-578.
3. Karakurum M, Shreeniwas R, Chen J, et al. Hypoxic induction of interleukin-8 gene expression in human endothelial cells. J Clin Invest 1994; 93: 1564-1570.
4. Ferreiro CR, Chagas AC, Carvalho MH, et al. Influence of hypoxia on nitric oxide synthase activity and gene expression in children with congenital heart disease: A novel pathophysiological adaptive mechanism. Circulation 2001; 103: 2272-2276.
5. Horigome H, Murakami T, Isobe T, Nagasawa T, Matsui A. Soluble P-selectin and thrombomodulin-protein C - protein S pathway in cyanotic congenital heart disease with secondary erythrocytosis. Thromb Res 2003; 112: 223-227.
6. Perloff JK, Hart EM, Greaves SM, Miner PD, Child JS. Proximal pulmonary arterial and intrapulmonary radiologic features of Eisenmenger syndrome and primary pulmonary hypertension. Am J Cardiol 2003; 92: 182-187.
7. Silversides CK, Granton JT, Konen E, Hart MA, Webb GD, Therrien J. Pulmonary thrombosis in adults with Eisenmenger syndrome. J Am Coll Cardiol 2003; 42: 1982-1987.
8. Caramurú LH, Maeda NY, Bydlowski SP, Lopes AA. Age-dependent likelihood of in situ thrombosis in secondary pulmonary hypertension. Clin Appl Thromb Hemost 2004; 10: 217-223.
9. Droste DW, Ritter MA, Monning G, Kemeny V, Breithhardt G, Ringelstein EB. Abundance of microembolic signals detected by transcranial doppler ultrasound in a patient with Eisenmenger's syndrome. Cerebrovasc Dis 1999; 9: 334-336.
10. Lopes AA, Soares RPS, Maeda NY. A mathematical framework for group analysis of von Willebrand factor multimeric composition following luminography. Braz J Med Biol Res 2002; 35: 1259-1263.
11. Takahashi H, Ito S, Hanano M, et al. Circulating thrombomodulin as a novel endothelial cell marker: Comparison of its behavior with von Willebrand factor and tissue-type plasminogen activator. Am J Hematol 1992; 41: 32-39.
12. Weir EK, Archer SL. The mechanism of acute hypoxic pulmonary vasoconstriction: The tale of two channels. FASEB J 1995; 9: 183-189.
13. Humbert M, Morrell NW, Archer SL, et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 2004; 43: 13S-24S.
14. Mandegar M, Fung Y-CB, Huang W, Remillard CV, Rubin LJ, Yuan JX-J. Cellular and molecular mechanisms of pulmonary vascular remodeling: Role in the development of pulmonary hypertension. Microvasc Res 2004; 68: 75-103.
15. Droma Y, Hanaoka M, Ota M, et al. Positive association of the endothelial nitric oxide synthase gene polymorphisms with high-altitude pulmonary edema. Circulation 2002; 106: 826-830.
16. Cacoub P, Dorent R, Maistre G, et al. Endothelin-1 in primary pulmonary hypertension and the Eisenmenger syndrome. Am J Cardiol 1993; 71: 448-450.
17. Cacoub P, Karmochkine M, Dorent R, et al. Plasma levels of thrombomodulin in pulmonary hypertension. Am J Med 1996; 101: 160-164.
18. Goerge T, Niemeyer A, Rogge P, Ossig R, Oberleithner H, Schneider SW. Secretion pores in human endothelial cells during acute hypoxia. J Membr Biol 2002; 187: 203-211.
19. Pinsky DJ, Naka Y, Liao H, et al. Hypoxia-induced exocytosis of endothelial cell Weibel-Palade bodies: A mechanism for rapid neutrophil recruitment after cardiac preservation. J Clin Invest 1996; 97: 493-500.
20. Dong J-F, Moake JL, Nolasco L, et al. ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions. Blood 2002; 100: 4033-4039.
21. Pimanda J, Hogg P. Control of von Willebrand factor multimer size and implications for disease. Blood Rev 2002; 16: 185-192.
22. Pareti FI, Lattuada A, Bressi C, et al. Proteolysis of von Willebrand factor and shear stress-induced platelet aggregation in patients with aortic valve stenosis. Circulation 2000; 102: 1290-1295.
23. Padilla A, Moake JL, Bernardo A, et al. P-selectin anchors newly released ultra-large von Willebrand factor multimers to the endothelial cell surface. Blood 2004; 103: 2150-2156.
24. Pepper MS, Rosnoblet C, Di Sanza C, Kruithof EK. Synergistic induction of t-PA by vascular endothelial growth factor and basic fibroblast growth factor and localization of t-PA to Weibel-Palade bodies in bovine microvascular endothelial cells. Thromb Haemost 2001; 86: 702-709.
25. Shreeniwas R, Ogawa S, Cozzolino F, et al. Macrovascular and microvascular endothelium during long-term hypoxia: Alterations in cell growth, monolayer permeability, and cell surface coagulant properties. J Cell Physiol 1991; 146: 8-17.
26. Esmon CT. The roles of protein C and TM in the regulation of blood coagulation. J Biol Chem 1989; 56: 151-157.
27. Ogawa S, Gerlach H, Esposito C, Pasagin-Macaulay A, Brett J, Stern D. Hypoxia modulates the barrier and coagulant function of cultured bovine endothelium. J Clin Invest 1990; 85: 1090-1098.
28. Healy AM, Hancok WW, Christie PD, Rayburn HB, Rosenberg RD. Intravascular coagulation activation in a murine model of thrombomodulin deficiency: Effects of lesion size, age, and hypoxia on fibrin deposition. Blood 1998; 92: 4188-4197.